As of June 2025 Ascendis Pharma has a market cap of A$15.92 Billion. This makes Ascendis Pharma the world's 1716th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$15.92 B | 20.43% |
2024 | A$13.21 B | 26.46% |
2023 | A$10.45 B | 2.14% |
2022 | A$10.23 B | -3.03% |
2021 | A$10.55 B | -8.9% |
2020 | A$11.58 B | 21.51% |
2019 | A$9.53 B | 154.46% |
2018 | A$3.74 B | 100.81% |
2017 | A$1.86 B | 105.11% |
2016 | A$0.90 B | 43.97% |
2015 | A$0.63 B |
On Jun 14th, 2025 the market cap of Ascendis Pharma was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Advaxis ADXS | A$1.96 M | -99.99% | ๐บ๐ธ USA |
![]() Affimed
AFMD | A$4.58 M | -99.97% | ๐ฉ๐ช Germany |
![]() Akebia Therapeutics AKBA | A$1.44 B | -90.95% | ๐บ๐ธ USA |